This study sought to determine the incidence and pattern of occurrence of Waldenstrom's macroglobulinemia, a plasmacytoid lymphocyte malignancy that involves monoclonal production of the IgM M-component type. Cases with WaldenstrOm's macroglobulinemia have been reported since 1978 to the population-based cancer registry that serves western Washington state, and since 1988 to the eight other cancer registries that participate in the National Cancer Institute's Surveillance, Epidemiology, and End-Results program. Persons less than 85 years old newly diagnosed with Waldenstrom's macroglobulinemia were identified through 1989. The age-standardized an-ALDENSTROM'S macroglobulinemia is a malignancy involving proliferation of cells with lymphocyte and plasma cell characteristics with consequent monoclonal production of IgM.' The disease occurs very infrequently, and its epidemiologic characteristics have not previously been reported. We conducted this study to estimate the incidence rate of Waldenstrom's macroglobulinemia and to characterize its occurrence by age, sex, race, and time.
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0004-4971/93/82l0-0023$3.00/0 nual incidence rate was 6.1 per million in white men and 2.5 per million in white women (1 980 US standard). Only five cases were reported in black women, among whom the age-standardized annual incidence rate was 3.6 per million. No cases were reported among black men (5.8 cases expected, based on the rates in white men); thisfinding may be due to chance, underdiagnosis of Waldenstrom's macroglobulinemia in this group, or may reflect a truly low rate. Further investigation of a large, racially diverse population is required to better characterize the epidemiology of this rare disease.
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lymph nodes, and (2) the patient has hepatosplenomegaly with hyperviscosity symptoms, coagulopathy, or cryoglobulinemia (R. Knierim, personal communication, January 1993). The cases in western Washington were reviewed by a single pathologist.
Estimates of the number of white and black men and women in each 5-year age group who were residents of each SEER surveillance area were available from SEER for the period 1978 through 1989. Age-standardized incidence rates were estimated separately for white and black men and women using the direct method, with 5-year age groups from the 1980 US population as the standard. Ninety-five percent confidence limits were approximated from the standard error of the log of the incidence rate for stratified data' for whites and black women. No black men were identified as having Waldenstriim's macroglobulinemia during the study period, and the investigators were not aware of a method to approximate the upper 95% confidence limit for stratified data with zero observations; thus, no upper confidence limit was estimated for this group.
RESULTS
There were 88 whites or blacks diagnosed as having Waldenstrom's macroglobulinemia in western Washington and 63 diagnosed in the remaining SEER areas. In western Washington, the annual age-standardized incidence rate was 7.9 (95% confidence interval [CI] 5.5 to 11) per million in white men and 2.9 (95% CI, 1.8 to 4.5) per million in white women. Among men, the reported incidence increased from 1978-1981 through 1982-1985, but decreased somewhat thereafter (Table I ). In women, there was a relatively low rate for the period 1982 through 1985, but no clear trend over the 12-year period.
In the eight other SEER locations, the annual incidence rates in white men and women were 4.9 (95% CI, 3.2 to 7.7) and 2.2 (95% CI, I .3 to 3.6) per million, respectively. The annual age-standardized incidence rate for the nine SEER areas combined was 6. I (95% CI, 4.4 to 8.2) per million in white men, 2.5 (95% CI, 1.7 to 3.5) per million in white women, and 3.6 (95% CI, I .2 to 11) per million in black women (Table 2) . No cases were reported in black men. Had the age-specific incidence rates in white men been present in the population of black men, 5.8 cases would have occurred. In whites, among whom there were enough cases to examine age-specific rates, incidence increased markedly with age; among men and women aged 80 to 84 years, the annual incidence was 41.9 and 16.7 per million, respectively ( Table 2 ). The cumulative risk of the disease to age 84 years, ie, the probability that an individual was diagnosed has a relatively high incidence of the disease, it would be necessary to explicitly evaluate this issue. Epidemiologic studies of Waldenstrom's macroglobulinemia have not been reported. However, it has been sugthe disease.7 In a series of 242 Mayo Clinic patients with IgM monoclonal gammopathy, among whom diagnoses of malignancy or amyloidosis were initially ruled out, the risk of the occurrence of Waldenstrom's macroglobulinemia, as
DISCUSSION
That no cases were reported among black men is of condefined on the basis of an increase in the size of the serum cern. One explanation is that Waldenstrom's macroglobuIgM spike to 3.0 g/dL or more and an increase in lympholinemia was underreported or misdiagnosed more frecytes or plasmacytoid lymphocytes in the bone marrow, quently in this group than in the other groups. This disease averaged 1.3% per year.7 This was approximately 1,000-fold has clinical features in common with multiple myeloma greater than the risk observed in the present study for a (annual age-adjusted incidence rate among white men and group with a similar age and sex distribution. While the women for the years 1985 through 1988, 84 and 58 per criteria used to diagnose IgM monoclonal gammopathy and million, respectively), non-Hodgkin's lymphoma (294 and Waldenstrom's macroglobulinemia in the Mayo Clinic 198 per million, respectively), chronic lymphocytic leukestudy differed from those used by SEER, the incidence of mia, and monoclonal gammopathy of unknown signifithe malignancy among the clinic patients undoubtedly was cance,' all of which occur much more frequently than Walelevated. Renier et a18 summarized 2 1 reports of families in denstrom's macr~globulinemia.~~' Indeed, it has been which multiple cases were diagnosed, but the question of a For personal use only. on October 23, 2017. by guest www.bloodjournal.org From heritable factor increasing risk for the disease has not been evaluated in an epidemiologic study. There has also been a report of three cases occumng in persons who had worked as shoe repairers for 40 years or 10nger.~ A second look at the descriptive epidemiology of Waldenstrom's macroglobulinemia would be appropriate in several years' time, after additional cases are identified in SEER populations beyond western Washington. However, a better understanding of the epidemiology of Waldenstrom's macroglobulinemia will await the results of studies of large, racially diverse populations in which ascertainment of this rare disease is relatively complete.
